Summary Little is known regarding the prevalence and course of fatigue in cancer patients after treatment has ended and no recurrence found. The present study examines fatigue in disease-free cancer patients after being treated with radiotherapy (n = 154). The (Breij and Visser. 1990). 61%7 of the subjects reported fatigue that w-as described as 'moderate to quite bad'. Treatment had ended more than 2 vears before the sunrey in 60%e of the sample. Lastly.
performed are mostly restricted to the period of treatment (Smets et al. 1993) . Consequently. little is known regarding the prevalence and course of fatigue following treatment. However. results from studies investigating psychological and physical distress in cancer survivors sunCest that some patients continue to experience fatigue long after treatment has ended. Devlen et al (1987) . for example. examined 120 newIly diagnosed patients with Hodgkin's or nonHodgkin's disease in a prospective study. Although most patients were no longer receivinr treatment and were free of cancer at 1-year follow-up. 42%7 of these patients continued to complain of loss of energy and 32% of tiredness. Fobair et al (1986) investigated the psychological problems that dexeloped in long-term surx iv%ors of Hodakin's disease. At a median time since treatment of 9 years. energy had not returned to their satisfaction in 37%7 of the patients. In a surxey among members of the Dutch patient organization of Hodgkin and non-Hodgkin patients (Breij and Visser. 1990 ). 61%7 of the subjects reported fatigue that w-as described as 'moderate to quite bad'. Treatment had ended more than 2 vears before the sunrey in 60%e of the sample. Lastly. Recefved 17 December 1997 Revised 17 March 1998 Accepted 1 Apnl 1998 Correspondernce to: EMA Smets Berglund et al ( 1991 ) assessed late effects of adjuvant treatment of breast cancer patients. free from recurrence 2-10 years after primary therapy. Patients who had received radiotherapy reported decreased stamina (75%7) more frequently than did chemotherapy patients (61%).
The mechanisms contributing to persistent fatigue in diseasefree cancer patients can only be speculated upon. Permanent changes in the immune or endocrine system. resulting, from treatment toxicit'. might cause a person to feel more fatigued. Treatment may also have resulted in permanent chanaes in physical functioning, such as chanaes in defecation pattern. in luna function caused by fibrosis of lungy tissue or in hormonal functioning (Leer and Van der Schueren. 1991 ). These in turn may bring about symptoms such as pain or shortness of breath and impairments in daily functioning, that in our study (see foreaoing article) and other studies (Irvine et al. 1994 : Belza. 1995 ha-e all been found to be associated with fatiaue. Immobilization has also been suacested as an explanation for persistent fatigue. Inactix ity resulting from prolonged periods of bed rest reduces the capacity for activity and produces an increased sense of effort for a gixen level of activity (Sharpe and Bass. 1992) . From a psy chological perspective. it is suggested that greater fatiguability resultincg from an impaired condition micht induce axoidance behaviour xhich. in the long, run. sustains feelinas of fatigue (Wessely et al. 1990 ). Chronic fatigue is also commonly found to be related to feelings of depression or anxiety (Wessely et al. 1990 : Ray. 1991 : Belza. 1995 .
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The symptom of fatigue is not specific for cancer. Prevalence rates between 14% and 34% of tiredness have been found in community surveys (Chen. 1986 : Rillsdale. 1991 : Lewis and Wessely. 1992 : Bensing and Schreurs. 1995 . In ambulatory care. fatigue is one of the most frequently reported problems. For example. Kroenke et al (1988) reported that of the 1159 patients surveyed from primary care clinics 24% indicated that fatigue had been a major problem for a month or more. In a study involving randomly selected patients of a health care centre. 45% were scored as fatigued (Valdini et al. 1987 ). More recently. Fuhrer and Wessely ( 1995) noted in their primary care sample that about onethird of all patients reported persistent symptoms of fatigue both in a self-administered questionnaire and to their physician. Results of a pnmary care study in the Netherlands indicate that fatigue is the third most frequent reason reported for consulting a primary physician (van Boven and Dijksterhuizen. 1993) .
To interpret the significance of results obtained in follow-up studies involving cancer patients. a comparison should therefore be made with persons without a history of cancer. Pickard-Holley (1991) made such a comparison and did not find any difference between a sample of 12 women receiving chemotherapy for ovarian cancer and a convenience sample of 12 apparently healthy women. Irvine et al (1994) compared fatigue in cancer patients (n = 101) with fatigue in healthy auxiliary staff (n = 53). Before the start of either radio-or chemotherapy treatment. no differences between groups were found. However. over the course of treatment. the degree of fatigue reported by patients was significantly higher than fatigue reported by the control subjects. Finally. Glaus (1993) compared the level of fatigue over 24-h periods of inpatients with cancer (n = 20). in-patients with chronic inflammatory gastrointestinal disease (n = 12) and healthy control subjects (n = 30). The profile over the day showed significant differences between these groups. In the morning, cancer patients had the highest level of fatigue compared with the other two groups. their fatigue slowly increasing during the day. The healthy control subjects started the day without tiredness. remained fit until the late afternoon and became very fatigued in the evening. However.
when the fatigue scores were averaged over a 24-h period. no significant differences between the groups were found.
These studies suffer from methodological weaknesses such as small sample sizes. heterogeneity with respect to diagnosis and treatment modality and/or the control groups being convenience samples. Also. all studies were restricted to the period of active cancer treatment.
This investigation examines fatigue in disease-free cancer patients after having been treated with radiotherapy. The research questions addressed are as follows. Firstly. how fatigued are patients 9 months after radiotherapy and how do they describe this experience. Secondly. to what degree is fatigue in disease-free patients associated with sociodemographic. medical and concurrent physical and psychological factors. Finally. is it possible to predict before the start of radiotherapy which patients will suffer from fatigue 9 months afterwards?
METHOD
Sample and procedure Disease-free patients Disease-free patients comprised consecutive cancer patients who had finished radiotherapy at the Academic Medical Centre in Amsterdam 9 months before and were disease free at the time of measurement. Eligibility criteria and the procedure are described in more detail in the preceding article in this issue. Patients were excluded from the 9-month follow-up when they had received additional cancer treatment following radiotherapy.
Reference group
The reference group consisted of a non-selective sample taken from the telephone directories of the same residential areas from which the patients were derived. A letter was sent to the selected residences to introduce the study. which was followed by a telephone call by the researchers. In order to prevent an overrepresentation of women. on the grounds of bein, more frequently at home when approached for participation. the next person to have a birthday within that residence was asked to participate. Respondents were to be at least 18 years of age.
Out of practical considerations. most respondents were requested to complete a home-sent questionnaire. To investigate a possible bias introduced by the difference in method as compared with the patients. a subgroup of respondents was invited to be interviewed at their home.
Respondents who declined participation were asked to give their date of birth and to rate their fatigue on a scale from 0 to lO in order to be able to assess selective drop-out.
Instruments Disease-free patients
All standard instruments used in the disease-free patients were similar to those described in the preceding article. Also. the same information from their medical charts was used (diagnosis. prognosis. radiation area and dose. fractionation). The following additional data were collected on interview: co-morbidity. the course of fatigue since end of treatment. frequency of fatigue (never. hardly ever. sometimes. most of the time or always), the time of most intense fatigue during the day (no clear pattern. early morning. noon. afternoon, late afternoon, evening). physical sensations associated with fatigue (muscle weakness, sweating. uncomfortable feeling in the chest. blurred sight and shortness of breath: with response categories not at all. a bit. moderate and very much). hours of sleep, the degree of concern (not at all. a bit. moderate, very much) and a comparison of their current fatigue with fatigue during the previous month (less intense. no difference, more intense) and with their expectations (worse than anticipated, as expected. better than anticipated).
Reference group Sociodemographic characteristics were recorded. Respondents completed the Multidimensional Fatigue Inventory (MFI-20) and the numerical scale for the assessment of fatigue. As in patients. additional questions addressed the frequency of fatigue. the time of most intense fatigue during the day. physical sensations associated with fatigue, hours of sleep and perceived cause of fatigue.
Statsical methods
Analyses involved descriptive statistics and one-way analyses of variance (ANOVAs) for the description of fatigue. To establish a possible effect of method of assessment in the reference group, MFI scores for the interview and questionnaire groups were compared using analyses of variance. As before. the score for Fatigue after radiotherapy 909 
Associated symptoms
The symptoms most frequently associated w-ith fatigue w-ere sweating (28%7c) and shortness of breath (24%7c) in patients. and sore muscles (37%7 ) and blurred siaht (28%7c) in the reference group.
Rest
Wlhen controlling for age. no significant differences between the two samples in frequency and duration of day-time napping. nor in amount of night-time sleep appeared.
Associations with fatigue at follow-up Results of the analyvses regardingy the concurrent. bivariate associations between fatigue and other factors at 9-month follow-up are presented in Table 3 . Women reported more fatigue than men. All A subsequent o erall regression analysis included the four variables that significantly predicted fatigue within their separate domains, taking their interrelatedness into account (see Table 4 ). The degree of fatigue. functional disability and pain at pretreatment contributed to the prediction of fatigue at follow-up. explaining 30%7. 4%c and 3%7 of the variance respectively. When pretreatment fatigue was not included. 22% of the variance in outcome was explained by the degree of post-treatment functional disability. DISCUSSION This is. to the best of our knowledge. the first investigation that has set out to investigate chronic fatigue in disease-free cancer patients. The only related study was conducted by Bloom et al (1990) . who investigated energy expenditure in patients with Hodgkin's disease 1-5 years after treatment.
The lack of difference in fatigue scores between disease-free patients and the reference group is noteworthy because the former group was expected to be more fatigued. Despite some resen-ations. which will be discussed later. this finding challenges the implicit assumption in studies on long-term effects that complaints of fatigue or lack of energy are characteristic for cancer survivors. As described. high prevalence rates of complaints of chronic fatigue are found in general population and primary care studies as well. In addition. previous investigations that included a non-cancer comparison group have also demonstrated comparable fatigue ratings for cancer patients and control subjects.
before (Irvine et al. 1994) or dunrng treatment (Pickard-Holley 1991 : Glaus. 1993 Glaus (1996) reached a similar conclusion on the basis of a qualitative comparison of the description of fatigue by cancer patients and healthy control subjects.
Another resersation with respect to the finding of equivalent fatigue scores in patients and the reference group is the problem of .response shift'. The term response shift refers to the change in a person's intemal standard for determining his or her level of functioning on a given dimension (Breetvelt en van Dam. 1991 : Sprangers. 1996 . The experience of fatigue dunrng radiotherapy could have changed a patient's standard of measurement concerning fatigue. What has been perceived to be 'intense' fatigue before treatment, might be labelled 'slightly' fatigued after having experienced exhaustion during treatment. The possible occurrence of a response shift complicates the interpretation of comparison data.
Finally. patients may himit their activities to such a degree that.
as a result, their fatigue does not exceed the level found in the general population.
Our findings suggest that medical characteristics such as diagnosis, prognosis and co-morbidity. and treatment characteristics such as total radiation dose. target area and fractionation are unrelated to long-term fatigrue. As indicated in the preceding article. this lack of impact may result from the heterogeneity of the study population and the crude assessment categories used.
The association between fatigue and psychological distress found. both concurrently and prospectis-ely. is consistent wvith the results from other research both in cancer (Nerenz et al. 1982 : Fobair et al. 1986 : lamar. 1989 : Blesh. 1991 ) and non-cancer populations (Fisk et al. 1994 : Fuhrer and Wessely. 1995 : Belza. 1995 . It underlines that the role of psychological distress should be taken into account when trying to alleviate fatigue.
As in the treatment-related study. no association between fatigue and neuroticism was found. This was unexpected. because negative affectivity has been found to correlate consistently and moderately with various measures of health complaints and physical symptoms (Watson and Pennebaker. 1989 ). This findina sugaests that fatigue reported by these patients cannot be considered to reflect a gyeneral tendency to complain. The lack of an association with optimism is more in line with the conclusion from Watson (1988) Functional disability. fatigue and pain, assessed before the start of treatment. together explained 37%/ of the -ariance in fatiaue at follow-up. This is a considerable amount of -ariance explained when takina into account that the variance in one symptom. more than 9 months later is predicted. However. it also demonstrates that it remains difficult to predict. on an individual basis. who w-ill suffer from long-term fatigue.
The findings presented must be considered w-ithin the limitations of this study. Our reference group was not necessarily an unbiased sample of the Dutch general population. Respondents were approached by means of telephone directories. which does not cover individuals who lack a telephone or those with unlisted numbers. Subjects who are registered tend to be more educated than subjects w-ho are not (Brambilla and McKinlav. 1987) . Also. by being dependent on telephone contact. persons being more frequently at home might be overrepresented. In view of the low response rate in the interview sample. other selection processes may also have affected the representativeness of this sample.
Respondents who refused to participate were found to be significantly more fatioued than participants. As previously stated.
patients who refused study participation were also found to be more tired than participants. As a result. the degree of fatigue of both patients and the general population in this investigation might be an underestimation of the problem.
Notw-ithstandin2 these limitations. the significant associations found in this investigation between fatigue and both psychological and physical variables again highlights that fatigue is a symptom with multiple factors contributing, to its manifestation. Consequently. a multidisciplinary approach seems warranted both for its investigation and treatment. Physical therapists in particular may offer a valuable contribution given the prominent role of functional disability in the prediction of fatigue.
Finally. one must beware of concluding that fatigue is a trivial complaint. Concluding that cancer patients 9 months after radiotherapy-seem not to differ from a population sample does not imply that fatiorue is clinically irrelevant. More than a third of the patients listed fatigue as one of the three symptoms causing them most distress. it worried about a quarter of the patients and it was negativelv and substantially related to the patient's evaluation of their quality of life. These data indicate that fatigue can be a very disturbing complaint.
